{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.0",
    "document_metadata": {
      "name": "Structural and functional properties of prefibrillar α-synuclein oligomers",
      "version": "1.0.0",
      "description": "",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "authors": "Esther Wollert and Charles Tapley Hoyt",
      "licenses": "CC BY 4.0",
      "contact": "charles.hoyt@scai.fraunhofer.de"
    },
    "namespace_url": {
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns",
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/chebi-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/785431732a26d6809b4162d98b95687d16404e63/export/hbp.belns"
    },
    "namespace_pattern": {},
    "namespaces_uncached": [],
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
    },
    "annotation_pattern": {},
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/knowledge/hbp_knowledge/pieri2016.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "calcium(2+)",
      "id": "4fb8648e4c5fea95cea6a46291d28175bba677d8b6fa8d607b1febef51c8370cbc1ff98d09312dc418ff31d04177d26f231d4f0a1a963f43fbc29cfb3269d3c9"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "dopamine",
      "id": "70f7314679db5bae3c2260b6feff9a6ef3407fb6a585f92a58c59fd066a2ec279c0091a72edba3465c4f2aa033afff7fded0b16c4a84f4bbcecd092a934ea66e"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "glutaraldehyde",
      "id": "479568e95dceb5f349964ab76e527f50c0d6ad3ea19c5ce3a12806394c760f319d24a59fb065dede470ab3f7d67f2a7d10e6a96293290e02396bf46c3e14c15b"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00016",
      "id": "224ab9fa08008ca2f4eb57b049669ffcecdfdf9b93189cdd4014bfd3ec6dcfb4a3e19393339e329dc1deda84b1d5217b8f8119cab299dd2d1ae9c7dac7fabb5f"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00092",
      "id": "a0ac4e8d87297ef18b7f53bf350a743997c3cbbf0b257d8bd7ec913783e660e33597d2bb7ba467829254c261fabf3258f1a992dc2e6eaa75435492cbbbb1c042"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00093",
      "id": "40583f1741facba41ac9f3de18ebe0de8c4c07f3a19bdf18429bffb135fd6a3207e9a3b64c32f9f5547bcd6ac00f8697383aa1b78b9abe1493fb7bc23d5dd87b"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "HBP00095",
      "id": "7064c41d452d204219d7446d495c4f46b0781b4a1eb7f8122e37f47c24eab0105815523ffd3324e0545e88899a22f8b7006570c00c2d1a5940f8e660076bc330"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "apoptotic process",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "ion homeostasis",
      "id": "e38537b0fbfe4a4bcfede663e4c6bcdd2094f69332250ca071529ffcac4bafad4d280789ef53c208fa19b6bfb12cff4b789f5948117daa1e16c4f8775662fbe9"
    },
    {
      "function": "BiologicalProcess",
      "namespace": "GO",
      "name": "neuron death",
      "id": "ad7c90f2bc746a5118759fd1c8857478c02207d574a26faaac9d6e4d6fa4661d8d87446139db0024a4011aae26027d3cabdfba663aec0ac0a8242868efb81dcd"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Lewy Body Disease",
      "id": "96e3a681a3c1aae0a3a2b158907153fc5e976e52d355cfecb0af2b5ab767bda982ed8c11b147dcfb04800986cc50e61613c751e724d8259e7863ae31adfd78f1"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Multiple System Atrophy",
      "id": "dcf233fd220ea77ede7d62fdce3d5d19ecdc8f55f9c7fb626a0fb6a4b183be9a4183e621a30e0cc8c69a6a1678d683f7e581e97d0995a5f4fd088a369157ed5f"
    },
    {
      "function": "Pathology",
      "namespace": "MESH",
      "name": "Parkinson Disease",
      "id": "d7f039170f83b3fcc27595412f3b0352cd1fe95f8481a2b1144ce311ac81bb5f0087a0a7e682f498d193e00b8e8fb29908a6e0b8e23da5ef349aeeb4723b9be0"
    }
  ],
  "links": [
    {
      "line": 40,
      "relation": "positiveCorrelation",
      "evidence": "Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are devastating synucleinopathies. The deposition of filamentous insoluble protein inclusions termed Lewy bodies and Lewy neurites whose main constituent is aggregated α -synuclein (α -syn) characterizes synucleinopathies.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 12,
      "target": 3,
      "key": "1804c8b2c08a5bdcb1b3dfaf1933181588db685ad0e4ebdf0ee3128f29e7dc09cefe78f9c94aa3c0dcd6bf27434e99f21d04f2edf9f2a358a09f89cfe472df91"
    },
    {
      "line": 40,
      "relation": "positiveCorrelation",
      "evidence": "Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are devastating synucleinopathies. The deposition of filamentous insoluble protein inclusions termed Lewy bodies and Lewy neurites whose main constituent is aggregated α -synuclein (α -syn) characterizes synucleinopathies.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 3,
      "target": 12,
      "key": "250d5a1f184077e5938d9564cfa0b4f9b4680195790e805def66aeae8a835ff4b30d26aada962c05f160308216b8ce770bd28d8619df160945e925051b24987b"
    },
    {
      "line": 41,
      "relation": "positiveCorrelation",
      "evidence": "Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are devastating synucleinopathies. The deposition of filamentous insoluble protein inclusions termed Lewy bodies and Lewy neurites whose main constituent is aggregated α -synuclein (α -syn) characterizes synucleinopathies.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 3,
      "target": 11,
      "key": "b00d4fd1ed1436e30ea95d69c2f5d25bb4f764cfb77656bb91b74c22f28716982a6fecd8198eea7f554c1dffedf70226008815707bef9e504cba27682e355231"
    },
    {
      "line": 42,
      "relation": "positiveCorrelation",
      "evidence": "Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are devastating synucleinopathies. The deposition of filamentous insoluble protein inclusions termed Lewy bodies and Lewy neurites whose main constituent is aggregated α -synuclein (α -syn) characterizes synucleinopathies.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 3,
      "target": 10,
      "key": "c30fba066cad536769e28bb9c0e1d7af77781ee30577658ebacdbfb63bf3c5ce49ac2b1ce40d99040ec9eb1c414ab06247c17e09fdf603f81f7bb3a5e2750773"
    },
    {
      "line": 41,
      "relation": "positiveCorrelation",
      "evidence": "Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are devastating synucleinopathies. The deposition of filamentous insoluble protein inclusions termed Lewy bodies and Lewy neurites whose main constituent is aggregated α -synuclein (α -syn) characterizes synucleinopathies.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 11,
      "target": 3,
      "key": "321e5aa9aa89f05e3fd9f0613423805313d99e5e81f90117a0b95376e73245e49a41aa8cc3363468194ab7c0471f4fe83d451a04fe311db74f29a84f0b5af782"
    },
    {
      "line": 42,
      "relation": "positiveCorrelation",
      "evidence": "Parkinson’s disease (PD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are devastating synucleinopathies. The deposition of filamentous insoluble protein inclusions termed Lewy bodies and Lewy neurites whose main constituent is aggregated α -synuclein (α -syn) characterizes synucleinopathies.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 10,
      "target": 3,
      "key": "073a33d6edce8aeb78b6deba82b4e003fc2a16051c06239474b80d528cdf1a3c18c05e79c7340d09b964feeb544bde23819e554a4af2000d9b99a6cb597f8cac"
    },
    {
      "line": 48,
      "relation": "increases",
      "evidence": "Prefibrillar oligomeric α -syn has been proposed to contribute to neurodegeneration by perturbing cellular ion homeostasis20, by seeding the assembly of soluble α -syn into higher molecular weight aggregates21, and/or by imbalancing cellular proteostasis22,23.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 6,
      "target": 9,
      "key": "3d1230a7e92400e80c81b02f45c3e4dfe0303b212b4d89b85388706f32c50e7459883e2ac030c32f82e823579cf39f7b6cc941b61786b8d63314c011cbc6b978"
    },
    {
      "line": 49,
      "relation": "decreases",
      "evidence": "Prefibrillar oligomeric α -syn has been proposed to contribute to neurodegeneration by perturbing cellular ion homeostasis20, by seeding the assembly of soluble α -syn into higher molecular weight aggregates21, and/or by imbalancing cellular proteostasis22,23.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 6,
      "target": 8,
      "key": "8ea55e6d8798e35cad6bb2f55c8bb34fc954b8cad4118f4c9d4fddab22564a716d5d3d5a083dc4d771837d9a369ce92b8eff9ae95554389a6c78ff8f6b8f6042"
    },
    {
      "line": 50,
      "relation": "increases",
      "evidence": "Prefibrillar oligomeric α -syn has been proposed to contribute to neurodegeneration by perturbing cellular ion homeostasis20, by seeding the assembly of soluble α -syn into higher molecular weight aggregates21, and/or by imbalancing cellular proteostasis22,23.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        }
      },
      "source": 6,
      "target": 3,
      "key": "34e14f936d78c8f7817e3abd0a929ed155d7539e21cdf9b6f44d8f036b9f60eee26497b4b3fc70681b2a6c919d902f1e2e22ed5e59cd994ff82f489a6b873626"
    },
    {
      "line": 57,
      "relation": "increases",
      "evidence": " The neurotransmitter dopamine (DA) has been shown to promote the formation of stable, SDS-resistant α -syn oligomers both in vitro and in neurons30–32 by different mechanisms, including the formation of stable α -syn-DA-quinone adducts, methionine oxidation, or non-covalent interactions33. ",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        }
      },
      "source": 1,
      "target": 5,
      "key": "556b2629746e4330fc7d785c479fd3dc8464118b0195211cefe398c72b8cf7602faf887e1fdc527e530854e83791a864988f5f63772361f347944e26c2a308ba"
    },
    {
      "line": 86,
      "relation": "increases",
      "evidence": "DA-mediated α -syn oligomers constitute a range of SDS-resistant species with apparent molecular weights ranging from over 2200 to 200 kDa as determined by SEC (Fig. 4a). ",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 1,
      "target": 5,
      "key": "032548ee361f9660cb2831e37aee4939435b45ee9b63c1a91b8eb5a283fdcc63aef04a8ba1acad09c52cbfd40e9eb51777916bba86b23b8a8ff6bca07fa4dcbb"
    },
    {
      "line": 70,
      "relation": "increases",
      "evidence": "1 nM (Fig. 3a, right panels and Fig. 3b, red curve, solid line) and 0.2 nM α -syn fibrils (Fig. 3b, red curve, dashed line) induced a progressive and significant increase of intracellular Ca2+ levels, as revealed by the rise of Fluo-4 fluorescence in exposed SH-SY5Y cells. In contrast, only a modest Ca2+ increase was observed in cells exposed to 300 nM on-fibrillar assembly pathway oligomeric α -syn (Fig. 3a, middle panels and Fig. 3b, blue curve, solid line) or 10 μM monomeric α -syn (Fig. 3a, left panels and Fig. 3b, black curve, solid line).",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 5,
      "target": 0,
      "key": "e19b687436bcf0a3af5d749ac8c463bb1b9e7ee92842675646039d7a6c5e5b9a1a25e734f9a23891c42f100a227bee2cc8cc91b12b6198deebc586c6e2929557"
    },
    {
      "line": 77,
      "relation": "increases",
      "evidence": "α -syn fibrils revealed to be highly toxic to cells at all the concentrations we tested, spanning 1 to 0.01 nM (53.4 ±  4% inhibition of MTT reduction at 0.01 nM, i.e. 0.1 μM equivalent monomer concentration) whereas α -syn oligomers only slightly impaired cell viability (23.9 ±  6% inhibition of MTT reduction at 300 nM, i.e. 10 μM initial monomer concentration) (Fig. 3c).",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 5,
      "target": 7,
      "key": "90bc8446b5c3893c0c6b03ece95ea46b87fb5bd27982f76bd9f71c2440af2157645fd8cde845081532cadd32de6ac72609f2840298284c3c5ead0b50e9d8bd9a"
    },
    {
      "line": 81,
      "relation": "negativeCorrelation",
      "evidence": "Increasing amounts of fibrils and a concomitant decrease in the amount of oligomeric species were observed upon longer incubation times (Supplementary Fig. S1). ",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 5,
      "target": 4,
      "key": "295667f9c0621518ed82b4ed719a545bc8209c41d4607cefff30cfdfb7768dcfc5be73ed02bbfd925ecdd3351c6c84590082d7982a4153e1ef10bedd22daab8f"
    },
    {
      "line": 69,
      "relation": "increases",
      "evidence": "1 nM (Fig. 3a, right panels and Fig. 3b, red curve, solid line) and 0.2 nM α -syn fibrils (Fig. 3b, red curve, dashed line) induced a progressive and significant increase of intracellular Ca2+ levels, as revealed by the rise of Fluo-4 fluorescence in exposed SH-SY5Y cells. In contrast, only a modest Ca2+ increase was observed in cells exposed to 300 nM on-fibrillar assembly pathway oligomeric α -syn (Fig. 3a, middle panels and Fig. 3b, blue curve, solid line) or 10 μM monomeric α -syn (Fig. 3a, left panels and Fig. 3b, black curve, solid line).",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 4,
      "target": 0,
      "key": "27aaed14fed4b856dee560e6b93967dcec61c2088aad8c408c6a357186ff999d59023184407fbf79e64ae3e876f6bdb12964bba71a76b3d92b8a2c7210e5c684"
    },
    {
      "line": 76,
      "relation": "increases",
      "evidence": "α -syn fibrils revealed to be highly toxic to cells at all the concentrations we tested, spanning 1 to 0.01 nM (53.4 ±  4% inhibition of MTT reduction at 0.01 nM, i.e. 0.1 μM equivalent monomer concentration) whereas α -syn oligomers only slightly impaired cell viability (23.9 ±  6% inhibition of MTT reduction at 300 nM, i.e. 10 μM initial monomer concentration) (Fig. 3c).",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 4,
      "target": 7,
      "key": "df7174a6fb679b26de0d2033f2c014c036154c8225e6ea85bcaf2c85aa66c50021e8ca4461727bc0bb99d8e15c6e5d23f036f58bcfda684c0eb4f4ea7b5bdd54"
    },
    {
      "line": 81,
      "relation": "negativeCorrelation",
      "evidence": "Increasing amounts of fibrils and a concomitant decrease in the amount of oligomeric species were observed upon longer incubation times (Supplementary Fig. S1). ",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 4,
      "target": 5,
      "key": "de9745aea0f0a8bf93c45add13ec7e87fd26a84b2acf5e2d79f10289cb91c930e29ca325231212c2f1bacfa9a00135786469fcd47c7605ea116ec251a29b7661"
    },
    {
      "line": 99,
      "relation": "increases",
      "evidence": "The high proportion of cells with overlapping ChFP and ATTO-488 puncta (89 ±  7% upon cell exposure to 0.06 nM ATTO-488-labeled α -syn fibrils, Fig. 6f) indicates that α -syn fibrils seed with high efficiency the aggregation of soluble cytoplasmic ChFP-α -syn.",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 4,
      "target": 3,
      "key": "076051d7d75ce26092f072b6205d9c9ab2e4f0e47f685d4fc0a7a460a7d5735d1872caad9dd4077475f0df9ff57fbd8afe4102f9fa4f7d18a56b6d0a7bb44be6"
    },
    {
      "line": 90,
      "relation": "increases",
      "evidence": "GA-cross-linked α -syn oligomers are also a heterogeneous set of SDS-resistant oligomeric species (Fig. 4b).",
      "citation": {
        "type": "PubMed",
        "reference": "27075649"
      },
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lewy Bodies": true
        },
        "Cell": {
          "neuron": true
        },
        "CellStructure": {
          "Intracellular Space": true
        }
      },
      "source": 2,
      "target": 5,
      "key": "00fe9640c0b8bfe231c18375777299063de3fce4b327399dd05ae9821e16dd9203dfb607b8796ee5b80c028de47b68e4f163f2eca8a9d9816a0749cffacf328c"
    }
  ]
}